Abstract
Bcl-2 was first identified as a novel transcript associated with the t(14;18) chromosomal breakpoint which occurs in most follicular lymphomas. The deregulated expression of bcl-2 was found to contribute to multistep neoplasia through the suppression of cell death, or apoptosis, in transgenic mouse models. Bcl-2 was subsequently shown to be normally expressed in a variety of tissues and to significantly inhibit the induction of apoptosis in many experimental systems. Bcl-2 is now known to be structurally similar to other proteins, in particular within the domains referred to as BH1 and BH2. This multigene family of cell death regulators includes members which enhance rates of apoptosis, including bcl-xs and bax, and those which inhibit apoptosis, including MCL-1 and bcl-xl. Members of the bcl-2 family physically interact with other proteins, including other family members and these interactions appear to modulate their function. The mechanism(s) by which bcl-2 family members regulate cell death remain in large part unknown, although recent evidence suggests that bcl-2 may interfere with cellular signalling events involved in apoptosis induction.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Literatur
Kerr J. F., Wyllie A. H. and Currie A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer26: 239–257
Camilleri-Broet S., Davi F., Feuillard J., Bourgeois C., Seilhean D., Hauw J. J. and Raphael M. (1985) Hight expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndromerelated primary brain lymphomas. Blood86: 432–435
Behl C., Hovey L., Krajewski S., Schubert D. and Reed, J. C. (1993) BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem. Biophys. Res. Commun.197: 949–956
Migheli A., Cavalla P., Piva R., Giordana M. T. and Schiffer D. (1994) Bcl-2 protein expression in aged brain and neurodegenerative diseases. Neuroreport15: 1906–1908
McDonnell T. J. (1993) Cell division versus cell death: a functional model of multistep neoplasia. Mol. Carcinogen.8: 209–213
Bakhshi A., Jensen J. P., Goldman P., Wright J. J., McBride O. W., Epstein A. L. and Korsmeyer S. J. (1985) Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell41: 899–906
Cleary M. L., Smith S. D. and Sklar J. (1986) Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18). Cell47: 19–28
Cleary M. L. and Sklar J. (1985) Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl Acad. Sci. USA83: 7439–7443
Tsujimoto Y., Cossman J., Jaffe E. and Croce C. M. (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science228: 1440–1443
Tsujimoto Y. and Croce C. M. (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl Acad. Sci. USA83: 5214–5218
Hsu B., Marin M. C., Brisbay S., McConnell K. and McDonnell T. J. (1994) Bcl-2 gene expression confers multidrug resistance to chemotherapeutic induced cell death. Cancer Bull.46: 125–129
Olsen C. W., Kehren J. C., Dybdahl-Sissoko N. R. and Hinshaw V. S. (1996) Bcl-2 alters influenza virus yield, spread and hemagglutinin glycosylation. J. Virol.70: 663–666
Vaux D. L., Weissman I. L. and Kim S. K. (1992) Prevention of programmed cell death inCaenorhaditis elegans by human bcl-2. Science258: 1955–1957
Miyashita T. and Reed J. C. (1992) Bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to death and DNA fragmentation induced by glucocorticoids and multible chemotherapeutic drugs. Cancer Res.52: 5407–5411
Strasser A. and Anderson R. L. (1995) Bcl-2 and thermotolerance cooperate in cell survival. Cell Growth Diff. 6: 799–805
Levine B., Huang Q., Isaacs J. T., Reed J. C., Griffin D. E. and Hardwick J. M. (1993) Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature361: 739–742
Hengartner M. O. and Horvitz H. R. (1994)C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell76: 665–676
Kamada S., Shimono A., Shinto Y., Tsujimura T., Takahashi T., Noda T., Kitamura Y., Kondoh H. and Tsujimoto Y. (1995) Bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation and distorted small intestine. Cancer Res.55: 354–359
Krajewski S., Tanaka S., Takayama S. Schibler M. J., Fenton W. and Reed J. C. (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes. Cancer Res.53: 4701–4714
Baffy G., Miyashita T., Williamson J. R. and Reed J. C. (1993) Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3 dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem.268: 6511–6519
Lam M., Dubyak G., Chen L., Nunez G., Miesfeld R. L. and Distelhorst C. W. (1994) Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc. Natl Acad. Sci. USA91: 6569–6573
Marin M. C., Fernandez A., Bick R. J., Bick R. J., Brisbay S., Buja L. M., Snuggs M., McConkey D. J., von Eschenbasch A. C., Keating M. J. and McDonnell T. J. (1996) Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+. Oncogene12: 2259–2266
Fernandez A., Marin M. C., McDonnell T. J. and Ananthaswamy H. N. (1994) Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblast to tumor necrosis factor: induction of bcl-2, c-myc and manganese superoxide dismutase in resistant cells. Oncogene9: 2009–2017
Jaattela M., Benedict M., Tewari M., Shayman J. A. and Dixit V. M. (1995) Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene10: 2297–2305
Talley A. K., Dewhurst S., Perry S. W., Dollard S. C., Gummuluru S., Fine S. M., New D., Epstein L. G., Gendelman H. E. and Gelbard H. A. (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidantN-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15: 2359–2366
Vandenabeele P., Declercq W., Vanhaesebroeck B., Grooten J. and Fiers W. (1995) Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J. Immunol.154: 2904–2913
Lotem J. and Sachs L. (1995) Regulation of bcl-2, bcl-xl and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Diff.6: 647–653
Vaux D. L., Aguila H. L. and Weissman I. L. (1992) Bcl-2 prevents death of factor- deprived cells but fails to prevent apoptosis in targets of cell mediated killing. Int. Immunol.4: 821–824
Reed J. C. (1994) Bcl-2 and the regulation of programmed cell death. J. Cell. Biol.124: 1–6
Oltvai Z. N., Milliman C. L. and Korsmeyer S. J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell74: 609–619
Yin X. M., Oltvali Z. N. and Korsmeyer S. J. (1994) BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature369: 272–273
Boise L. H., Gonzalez-Garcia M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nunez G. and Thompson, C. B. (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell74: 597–608
Kozopas K. M., Yang T., Buchan H. L., Zhou P. and Craig R. W. (1993) MCL-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl Acad. Sci. USA90: 3516–3520
Yang E., Zha J., Jockel J., Boise L. H., Thompson C. B. and Korsmeyer S. J. (1995) Bad, a heterodimeric partner for Bcl-Xll and Bcl-2, displaces Bax and promotes cell death. Cell80: 285–291
Seto M., Jaeger U., Hockett R. D., Graninger W., Bennett S., Goldman P. and Korsmeyer S. J. (1988) Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J.7: 123–131
Young R. L. and Korsmeyer S. J. (1993) A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Mol. Cell. Biol.13: 3686–3697
Hockenbery D. M., Nunez G., Milliman C., Schreiber R. D. and Korsmeyer S. J. (1990) Bcl-2 in inner mitochondrial membrane protein that blocks programmed cell death. Nature348: 334–336
Nguyen M., Branton P. E., Walton P. A., Oltvai Z. N., Korsmeyer S. J. and Shore G. C. (1994) Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus. J. Biol. Chem.269: 16521–16524
Nguyen M., Millar D. G., Yong V. M., Korsmeyer S. J. and Shore G. C. (1993) Targeting of Bcl-2 to the mitochondrial outer membrane by a COOH-terminal signal anchor sequence. J. Biol. Chem.268: 25265–25268
Borner C., Martinou I., Mattman C., Irmler M., Schaerer E., Martinou J. C. and Tschopp J. (1994) The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell Biol.126: 1059–1068
Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L. and Korsmeyer S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell75: 241–251
Akao Y., Otsuki Y., Kataoka S., Ito Y. and Tsujimoto Y. (1994) Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res.54: 2468–2471
Chen-Levy Z. and Cleary M. L. (1990) Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J. Biol. Chem.265: 4929–4933
Chen-Levy Z., Nourse J. and Cleary M. L. (1989) The bcl-2 candidate proto-oncogene product is a 24-kilodalton integralmembrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation. Mol. Cell Biol.9: 701–710
de Jong D., Prins F. A., Mason D. Y., Reed J. C., van Ommen G. B. and Kluin P. M. (1994) Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells. Cancer Res.54: 256–260
Givol I., Tsarfaty I., Resau J., Rulong S., da Silva P. P., Nasioulas G., Du Hadaway J., Hughes S. H. and Ewert D. L. (1994) Bcl-2 expressed using a retroviral vector is localized primarily in the nuclear membrane and the endoplasmic reticulum of chicken embryo fibroblasts. Cell Growth Diff.5: 419–429
Janiak F., Leber B. and Andrews D. W. (1994) Assembly of Bcl-2 into microsomal and outer mitochondrial membranes. J. Biol. Chem.269: 9842–9849
Lithgow T., van Driel R., Bertram J. F. and Strasser A. (1994) The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum and the outer mitochondrial membrane. Cell Growth Diff.5: 411–417
Yin X. M., Oltvai Z. N. and Korsmeyer S. J. (1995) Heterodimerization with Bax is required for Bcl-2 to repress cell death. Curr. Top. Microbiol. Immunol.194: 331–338
Hanada M., Aimé-Sempé C., Sato T. and Reed J. C. (1995) Structure-function analysis of Bcl-2 protein: identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J. Biol. Chem.270: 11962–11969
Tanaka S., Saito K. and Reed J. C. (1993) Structure-function analysis of the Bcl-2 oncoprotein: addition of a heterologous transmembrane domain to portions of the Bcl-2 beta protein restores function as a regulator of cell survival. J. Biol. Chem.268: 10920–10926
Korsmeyer S. J., Shutter J. R., Veis D. J., Merry D. E. and Oltvai Z. N. (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Seminars in Cancer Biology4: 327–332
Sedlak T. W., Oltvai Z. N., Yang E., Wang K., Boise L. H., Thompson C. B. and Korsmeyer S. J. (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl Acad. Sci. USA92: 7834–7838
McDonnell T. J., Deane N., Platt F. M., Nunez G. Jaeger U., McKearn J. P. and Korsmeyer S. J. (1989) Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell57: 79–88
McDonnell T. J., Nunez G., Platt F. M., Hockenbery D., London L., McKearn J. P. and Korsmeyer S. J. (1990) Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol. Cell. Biol.10: 1901–1907
McDonnell T. J. and Korsmeyer S.J. (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature349: 254–256
Marin M. C., Hsu B., Stephens L. C., Brisbay S. and McDonnell T. J. (1995) The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp. Cell Res.217: 240–247
McDonnell T. J. (1993) The bcl-2 immunoglobulin transgenic mouse: a model of the t(14;18) translocation in human follicular lymphoma. Transgene1 47–52
McDonnell T. J., Marin M. C., Hsu B., Brisbay S. M., McConnell K., Tu S.-M., Campbell M. L. and Rodriguz-Villanueva G. (1993) The bcl-2 oncogene: apoptosis and neoplasia. Radiat. Res.136: 307–312
Nakayama K., Negishi I. Kuida K., Sawa H. and Loh D. Y. (1994) Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease and lymphocytopenia. Proc. Natl Acad. Sci. USA91: 3700–3704
Veis D. J., Sorenson C. M., Shutter J. R. and Korsmeyer S. J. (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell75: 229–240
Nicotera P., Zhivotovsky B. and Orrenius S. (1994) Nuclear calcium transport and the role of calcium in apoptosis. Cell Calcium16: 279–288
Kumar S., Kinoshita M., Noda M., Copeland N. G. and Jenkins N. A. (1994) Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of theCaenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme. Genes Dev.8: 1613–1626
Kane D. J., Sarafian T. A., Anton R., Hahn H., Gralla E. B., Valentine J. S., Ord T. and Bredesen D. E. (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science262: 1274–1277
Jacobson M. D. and Raff M. C. (1995) Programmed cell death and Bcl-2 protection in very low oxygen. Nature374: 814–816
Shimizu S., Eguchi Y., Kosaka H., Kamiike W., Matsuda H. and Tsujimoto Y. (1995) Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xl. Nature374: 811–813
Ellis H. M. and Horvitz H. R. (1986) Genetic control of programmed cell death in the nematodeC. elegans. Cell44: 817–829
Hengartner M. O., Ellis R. E. and Horvitz H. R. (1992)Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature356: 494–499
Hengartner M. O. and Horvitz H. R. (1994) Activation ofC. elegans cell death protein CED-9 by an amino-acid substitution in a domain conserved in Bcl-2. Nature369: 318–320
Miura M., Zhu H., Rottelo R., Hartwieg E. A. and Yuan J. (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of theC. elegans cell death gene ced-3. Cell75: 653–660
Yuan J., Shaham S., Ledoux S., Ellis H. M. and Horvitz H. R. (1993) TheC. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell75: 641–652
Darmon A. J., Nicholson D. W. and Bleackley R. C. (1995) Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature377: 446–448
Fernandes-Alnemri T., Litwack G. and Alnemri E. S. (1994) CPP32, a novel human apoptotic protein with homology toCaenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem.269: 30761–30764
Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M. and Lazebnik Y. A. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature376: 37–43
Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., Poirier G. G., Salvesen G. S., Dixit V. M. (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell81: 801–809
Chinnaiyan A. M., Orth K., O'Rourke K., Duan H., Poirier G. G. and Dixit V. M. (1996) Molecular ordering of the cell death pathway: bcl-2 and bcl-Xl function upstream of the ced-3-like apoptotic proteases. J. Biol. Chem.271: 4573–4576
Henderson S., Huen D., Rowe M., Dawson C., Johnson G. and Rickinson A. (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl Acad. Sci. USA90: 8479–8483
Chiou S. K., Tseng C. C., Rao L. and White E. (1994) Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol.68: 6553–6566
Apte S. S., Mattei M. G. and Olsen B. R. (1995) Mapping of the human BAX gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, BAX delta. Genomics26: 592–594
Cheng E. H.-Y., Levine B., Boise L. H., Thompson C. B. and Hardwick, J. M. (1996) Bax-independent inhibition of apoptosis by bcl-xl. Nature379: 554–556
Krajewski S., Krajewska M., Shabaik A. and Reed J. C. (1994) Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am. J. Pathol.145: 1323–1336
Knudson C. M., Tung K. S., Tourtellotte W. G., Brown G. A. and Korsmeyer S. J. (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science270: 96–99
Miyashita T. and Reed J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell80: 293–299
Zhan Q., Fan S., Bae I., Guillouf C., Liebermann D., O'Connor P. and Fornace A. J. Jr. (1994) Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene9: 3743–3751
Miyashita T., Krajewski S., Krajwaska M., Wang H. G., Lin H. K., Liebermann D. A., Hoffman B. and Reed J. C. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene9: 1799–1805
Miyashita T., Kitada S., Krajewski S., Horne W. A., Delia D. and Reed J. C. (1995) Overexpression of the bcl-2 protein increases the half-life of p21 (bax). J. Biol. Chem.270: 26049–26052
Bargou R. C., Daniel P. T., Mapara M. Y., Bommert K., Wagener C., Kallinich B., Royer H. D. and Dorken B. (1995) Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer60: 854–859
Krajewski S., Blomqvist C., Franssila K., Krajewska M., Wasenius V. M., Niskanen E., Nordling S. and Reed J. C. (1995) Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res.55: 4471–4478
Sato T., Hanada M., Bodrug S., Irie S., Iwama N., Boise L. H., Thompson C. B., Golemis E., Fong L. and Wang H. G. (1994) Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hydrid system. Proc. Natl Acad. Sci. USA91: 9238–9242
Gonzalez-Garcia M., Perez-Ballestro R., Ding L., Duan L., Boise L. H., Thompson C. B. and Nunez G. (1994) Bcl-x is the major mRNA form expressed during murine development and its product localizes to the mitochondria. Development120: 3033–3042
Krajewski S., Krajwaska M., Shabaik A., Wang H. G., Irie S., Fong L. and Reed J. C. (1994) Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res.54: 5501–5507
Rouayrenc J. F., Boise L. H., Thompson C. B., Privat A. and Patey G. (1995) Presence of the long and the short forms of Bcl-X in several human and murine tissues. Life Sciences318: 537–540
Park J. R., Bernstein I. D. and Hockenbery D. M. (1995) Primitive human hematopoietic precursors express bcl-x but not bcl-2. Blood86: 868–876
Motoyama N., Wang F., Roth K. A., Sawa H., Nakayama K., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S. and Loh D. Y. (1995) Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science267: 1506–1510
Choi M. S. and Boise L. H. (1995) The role of bcl-Xl in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol.25: 1352–1357
Gottschalk A. R., Boise L. H., Thompson C. B. and Quintans J. (1994) Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc. Natl. Acad. Sci. USA91: 7350–4735
Chittenden T., Harrington E. A., O'Connor R., Flemington C., Lutz R. J., Evan G. I. and Guild B. C. (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature374: 733–736
Farrow S. N., White J. H., Martinou I., Raven T., Pun K. T., Grinham C. J., Martinou J. C. and Brown R. (1995) Cloning of a bcl-2 homologue by interaction with adenovirus E1B. Nature374: 731–733
Kiefer M. C., Brauer M. J., Powers V. C., Wu J. J., Umansky S. R., Tomei L. D. and Barr P. J. (1995) Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature374: 736–739
Lin E. Y., Orlofsky A., Berger M. S. and Prystowsky M. B. (1993) Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol.151: 1979–1988
Yang T., Kozopas K. M. and Craig R. W. (1995) The intracellular distribution and pattern of expression of MCL-1 overlap with, but are not identical to, those of Bcl-2. J. Cell Biol.128: 1173–1184
Craig R. W., Jabs E. W., Zhou P., Kozopas K. M., Hawkins A. L., Rochelle J. M., Seldin M. F. and Griffin C. A. (1994) Human and mouse chromosomal mapping of the myeloid cell leukemia-1 gene: MCL-1 maps to human chromosome 1q21, a region that is frequently altered in preneoplastic and neoplastic disease. Genomics23: 457–463
Atkin N. (1986) Chomosome 1 aberrations in cancer. Cancer Genet. Cytogenet.21: 279–285
Gendler S. J., Cohen E. P., Craston A., Duhig T., Johnstone G. and Barnes D. (1990) The locus of the polymorphic epithelial mucin (PEM) tumour antigen on chromosome 1q21 shows a high frequency of alteration in primary human breast cancer. Int. J. Cancer45: 431–435
Testa J. R. (1990) Chromosome translocations in human cancer. Cell Growth Diff.1: 97–101
Bodrug S. E., Aimé-Sempé C., Sato T., Krajewski S., Hanada M. and Reed, J. C. Biochemical and functional comparisons of MCL-1 and Bcl-2 proteins: evidence for a novel mechanism of regulating bcl-2 family function. Cell Death Diff. (in press)
Reynolds J. E., Yang T., Qian L., Jenkinson J. D., Zhou P., Eastman A. and Craig R. W. (1994) MCL-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res.54: 6348–6352
Lømo J., Smeland E. B., Krajewski S., Reed J. C. and Blomhoff H. K. (1996) Expression of the bcl-2 homologue MCL-1 correlates with survival of peripheral bloodB lymphocytes. Cancer Res.56: 40–43
Krajewski S., Bodrug, S., Krajewska M., Shabaik A., Gascoyne R., Berean K. and Reed J. C. (1995) Immunohistochemical analysis of MCL-1 protein in human tissues: differential regulation of MCL-1 and Bcl-2 protein production suggests a unique role for MCL-1 in control of programmed cell death in vivo. Am. J. Pathol.146: 1309–1319
Krajewski S., Bodrug S., Gascoyne R., Berean K., Krajewska M. and Reed J. C. (1994) Immunohistochemical analysis of MCL-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am. J. Pathol.145: 515–525
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McDonnell, T.J., Beham, A., Sarkiss, M. et al. Importance of the Bcl-2 family in cell death regulation. Experientia 52, 1008–1017 (1996). https://doi.org/10.1007/BF01920110
Issue Date:
DOI: https://doi.org/10.1007/BF01920110